Streptococcal B vaccine (Emergent BioSolutions)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStreptococcal B vaccine (Emergent BioSolutions)
Drug Alias NameGBS vaccine - Emergent BioSolutionsEBS-A42EBS-C12
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStreptococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmergent Biosolutions Inc
Active IndicationsN/A
Inactive IndicationsStreptococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A